Synthesis and Biological Activities of ( R )-5,6-Dihydro- N , N -dimethyl-4 H -imidazo[4,5,1- ij ]quinolin-5-amine and Its Metabolites
β Scribed by Heier, Richard F.; Dolak, Lester A.; Duncan, J. Neil; Hyslop, Deborah K.; Lipton, Michael F.; Martin, Iain J.; Mauragis, Michael A.; Piercey, Montford F.; Nichols, Nanette F.; Schreur, Peggy J. K. D.; Smith, Martin W.; Moon, Malcolm W.
- Book ID
- 119945819
- Publisher
- American Chemical Society
- Year
- 1997
- Tongue
- English
- Weight
- 441 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0022-2623
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract (__R__)β5β(diallylamino)β5,6βdihydroβ4__H__βimidazo[4,5,1β__ij__]quinolinβ2(1__H__)βone (__12b__) was prepared in 9% overall yield from 3βaminoquinoline. Reaction of __12b__ in ethyl acetate with tritium gas in presence of a 5% platinum on carbon catalyst afforded a mixture of (__R__)β5
Synthesis and Diuretic Activity of 4,5-Dihydro-6H-imidazo[4,5,1ij]quinoline-6-one 6-Oxime-O-sulfonic Acid Derivatives. -Among a variety of prepared title compounds, e.g. (I), (II), and (III), derivatives (I) show diuretic activity comparable, cf. (Ia) and (Ib), or superior, cf. (Ic), to that of M17
## ~R~ 5, quinolin-2( lm-one (1) is a dopamine agonist which shows selectivity for the D2 receptor subtype, and is of interest as a potential drug for the treatment of Parkinson's disease. An asymmetric epoxidation approach has been used to prepare 1 in eleven steps (15% overall yield) from 8-nit